Back to Search Start Over

Comprehensive health status and health-related quality of life of children at diagnosis of high-risk neuroblastoma: a multicentric pilot study.

Authors :
Viani K
Furlong W
Filho VO
Santos Murra MD
Nabarrete JM
Ladas E
Barr RD
Source :
Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2024 Sep 07. Date of Electronic Publication: 2024 Sep 07.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Background: Neuroblastomas account for 8-10 % of all cancer diagnoses among children. Most patients present with advanced, high-risk disease and 90 % are less than five years old. The burden of morbidity and mortality is high and is quantifiable by measures of health-related quality of life (HRQL). Measuring quality of life in under five-year-old children is a particular challenge that has been met with the development of the Health Utilities Pre-School (HuPS) instrument. Quality of life studies in children with cancer are scarce in low- and middle-income countries and are usually conducted at a single center, thus limiting any conclusions drawn. This pilot study aimed to assess the health-related quality of life of children at the time of diagnosis of high-risk neuroblastomas.<br />Method: This prospective cross-sectional multicentric study assessed the quality of life of children with high-risk neuroblastoma. The Health Utilities Pre-School instrument was applied to under five-year-olds, and the related Health Utilities Index Mark 3 instrument to over five-year olds.<br />Main Results: Eleven patients participated in this study. There was a high burden of morbidity at diagnosis, often equating to severe disability, indicative of states of health with scores worse than being dead in two under five-year-old children.<br />Conclusion: The results of the current study will help to set research priorities for subsequent investigations and provide a basis to improve supportive care for children with high-risk neuroblastoma.<br />Competing Interests: Conflicts of interest The authors have no competing interests to declare.<br /> (Copyright © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. All rights reserved.)

Details

Language :
English
ISSN :
2531-1387
Database :
MEDLINE
Journal :
Hematology, transfusion and cell therapy
Publication Type :
Academic Journal
Accession number :
39304372
Full Text :
https://doi.org/10.1016/j.htct.2024.05.014